Testing a new wearable device for measuring blood oxygen levels

Controlled Desaturation Study for Perin Health Patch Pulse Oximetry Validation

Perin Health Devices · NCT06680700

This study is testing a new wearable device that measures blood oxygen levels in healthy adults to see how well it works compared to standard devices.

Quick facts

Study typeObservational
Enrollment25 (estimated)
Ages18 Years to 50 Years
SexAll
SponsorPerin Health Devices (industry)
Locations1 site (Woodland Hills, California)
Trial IDNCT06680700 on ClinicalTrials.gov

What this trial studies

This observational study evaluates the accuracy of the Perin Health Patch (PHP), a non-invasive device worn on the chest that continuously measures blood oxygen saturation. Participants will breathe low-oxygen air to simulate various oxygen levels while their readings are compared to standard pulse oximeters. The study aims to assess the PHP's performance under controlled conditions, ensuring it meets safety standards and can provide reliable data for remote monitoring. Up to 25 healthy adults will participate in this single-site study, which includes controlled desaturation sessions and monitoring by clinical staff.

Who should consider this trial

Good fit: Ideal candidates are healthy adults aged 18 to 50 who are fully vaccinated for COVID-19 and can comply with study procedures.

Not a fit: Patients with pre-existing conditions such as heart or lung diseases, or those over 50 years old, may not benefit from this study.

Why it matters

Potential benefit: If successful, this device could enable continuous and accurate monitoring of blood oxygen levels in patients at home.

How similar studies have performed: While similar studies have explored wearable devices for monitoring vital signs, the specific approach of the PHP in this controlled setting is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years to 50 years
* The subject is in good general health with no evidence of any medical problems,
* Fully vaccinated for COVID-19
* Fluent in both written and spoken English
* Willing and able to provide informed consent,
* Able to comply with study procedure.

Exclusion Criteria:

* Children (under the age of 18)
* Adults above 50 years old
* History of heart, lung, kidney, or liver disease.
* Obesity (BMI \> 30),
* Diagnosis of asthma, sleep apnea, or use of CPAP.
* Diagnosis of Raynaud's disease
* Unacceptable collateral circulation based on an exam by the investigator (Allen's test).
* Pregnant, lactating or trying to get pregnant
* Current smoker
* History of diabetes
* Clotting disorder
* Hemoglobinopathy or history of anemia
* History of fainting or vasovagal response
* Any other serious systemic illness
* Any other condition which, in the opinion of the investigators, would make them unsuitable for the study,
* Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly,
* Any evidence, in the opinion of the investigators, of medical problems or poor general health
* Any symptoms related to COVID-19
* No vaccinated for COVID-19
* Recent injection with methylene blue
* History of reactions to medical adhesives,
* Unable or unwilling to provide informed consent,
* Inability to comply with the study procedure,
* Non-English Speaker.

Where this trial is running

Woodland Hills, California

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Oxygen Saturation Measurement, Pulse Oximeter, Oxygen Saturation, Wearable

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.